ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 85 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $360,000 | +35.3% | 616,402 | +64.7% | 0.05% | +50.0% |
Q1 2022 | $266,000 | -40.5% | 374,276 | +10.5% | 0.04% | -35.7% |
Q4 2021 | $447,000 | -48.1% | 338,756 | -9.6% | 0.06% | -36.4% |
Q3 2021 | $862,000 | -57.1% | 374,811 | +35.6% | 0.09% | -73.6% |
Q1 2021 | $2,007,000 | +4263.0% | 276,381 | +2484.0% | 0.33% | +4062.5% |
Q4 2020 | $46,000 | -2.1% | 10,696 | -5.7% | 0.01% | 0.0% |
Q3 2020 | $47,000 | -62.1% | 11,347 | -45.2% | 0.01% | -88.4% |
Q2 2020 | $124,000 | – | 20,707 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |